Affiliate disclosure: vendor links in this article are affiliate links — The Peptide Catalog may earn a commission if you buy through them, at no additional cost to you.
Ready to buy? Compare verified vendors on our best Wolverine Stack sources page, or browse all coupon codes for up to 50% off.
Where These Numbers Come From
The Wolverine Stack combines two well-established healing peptides at doses that align with their individual standalone protocols.
BPC-157 (Sikiric et al., 2018): Drives angiogenesis via VEGF, activates FAK-paxillin pathway in tendon fibroblasts (Chang et al., 2011), and upregulates GH receptor expression. The 250 mcg per-peptide dose is at the lower end of standalone BPC-157 protocols (250-500 mcg/day) — appropriate for a combination approach.
TB-500 (Malinda et al., 1999): LKKTET actin-binding domain promotes cell migration and anti-fibrotic tissue organization (Sosne et al., 2010). The 250 mcg per-peptide dose is below standalone TB-500 protocols (500 mcg/day) but provides complementary coverage alongside BPC-157.
Combination evidence (Lee & Padgett, 2021): A retrospective study compared BPC-157 alone to BPC-157 + Thymosin Beta-4 for knee pain. While limited (small sample, retrospective design), patients receiving the combination showed improved pain scores.
The synergy is straightforward: BPC-157 builds repair infrastructure (blood vessels, growth factors), TB-500 moves repair cells into position (migration, actin remodeling). One creates the environment; the other populates it.
Wolverine Stack vs Glow vs Klow
Feature Wolverine Stack (20mg) Glow (70mg) Klow (80mg) BPC-157 10 mg 10 mg 10 mg TB-500 10 mg 10 mg 10 mg GHK-Cu -- 50 mg 50 mg KPV -- -- 10 mg Best for Pure injury recovery Repair + collagen/anti-aging Repair + inflammation Typical price Lower Mid Higher
Wolverine Stack is most commonly chosen for pure injury recovery, tendon/joint healing, or post-surgical repair. Glow is the common choice for repair combined with collagen and anti-aging goals. Klow is commonly chosen when chronic inflammation is also a priority.
Stacking Protocols
Wolverine Stack + GHK-Cu
Peptide Dose Route Timing Purpose Wolverine Stack 500 mcg daily SC AM Tissue repair + cell migration GHK-Cu 1-3 mg 2x/week SC AM Collagen synthesis, gene activation
Or just buy the Glow blend which includes GHK-Cu pre-mixed.
Wolverine Stack + Ipamorelin
Peptide Dose Route Timing Purpose Wolverine Stack 500 mcg daily SC AM Tissue repair Ipamorelin 100-200 mcg SC Pre-bed GH release for enhanced recovery
BPC-157's GH receptor upregulation may synergize with increased GH output from Ipamorelin.
Side Effects & Safety
Injection site reactions — redness, minor swelling (resolves within hours) Mild nausea — occasionally in the first few days at higher doses Lightheadedness — uncommon, related to BPC-157's NO pathway activity Fatigue — some report temporary tiredness in week 1 as repair ramps up No human clinical trials for the BPC-157/TB-500 combination Theoretical cancer concern — angiogenesis + cell migration peptides; no evidence of tumor promotion, but caution with active cancer Purchase from COA-tested vendors — purity matters with research-grade compounds
mg to Units Conversion
On a standard 100-unit insulin syringe, each "unit" equals 0.01 mL (so 100 units = 1 mL). Because this is a pre-mixed blend, a single draw delivers all components together in fixed ratio. BPC-157 and TB-500 are present at the same concentration, so each draw delivers an equal dose of both.
At the standard reconstitution from the Quick Reference above (20 mg vial + 2 mL BAC water, 5,000 mcg/mL each), target doses convert as follows.
Dose (each peptide) Volume (mL) Units (insulin syringe) 125 mcg BPC-157 + 125 mcg TB-500 0.025 mL 2.5 units 250 mcg BPC-157 + 250 mcg TB-500 0.05 mL 5 units 375 mcg BPC-157 + 375 mcg TB-500 0.075 mL 7.5 units 500 mcg BPC-157 + 500 mcg TB-500 0.1 mL 10 units
These conversions reflect the dilutions documented in community reconstitution protocols. They report how the math is described, not a recommended dosing schedule.